{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:07:22Z","timestamp":1787843242213,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES027706"],"award-info":[{"award-number":["ES027706"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES022981, ES036206"],"award-info":[{"award-number":["ES022981, ES036206"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL035464, HL060712"],"award-info":[{"award-number":["HL035464, HL060712"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK119268, DK126698, DK120870, DK129670"],"award-info":[{"award-number":["DK119268, DK126698, DK120870, DK129670"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["U01CA167552, R01HL35464, UM1 CA186107, R01 HL034594 and R01 CA49449"],"award-info":[{"award-number":["U01CA167552, R01HL35464, UM1 CA186107, R01 HL034594 and R01 CA49449"]}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","award":["UL1 TR002541"],"award-info":[{"award-number":["UL1 TR002541"]}],"id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Health"],"DOI":"10.1186\/s12940-024-01147-2","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T10:31:04Z","timestamp":1733221864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women"],"prefix":"10.1186","volume":"23","author":[{"given":"Lu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binkai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Rimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"1147_CR1","unstructured":"PFAS chemicals overview | ATSDR. January 17, 2024. https:\/\/www.atsdr.cdc.gov\/pfas\/health-effects\/overview.html.\u00a0Accessed 6 May 2024."},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.envint.2013.03.008","volume":"57\u201358","author":"T Fletcher","year":"2013","unstructured":"Fletcher T, Galloway TS, Melzer D, et al. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans. Environ Int. 2013;57\u201358:2\u201310. https:\/\/doi.org\/10.1016\/j.envint.2013.03.008.","journal-title":"Environ Int"},{"issue":"4","key":"1147_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.reprotox.2011.09.009","volume":"33","author":"CJ Wolf","year":"2012","unstructured":"Wolf CJ, Schmid JE, Lau C, Abbott BD. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPAR\u03b1) by perfluoroalkyl acids (PFAAs): Further investigation of C4\u2013C12 compounds. Reprod Toxicol. 2012;33(4):546\u201351. https:\/\/doi.org\/10.1016\/j.reprotox.2011.09.009.","journal-title":"Reprod Toxicol"},{"issue":"6","key":"1147_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/ATVBAHA.107.158998","volume":"28","author":"E Rigamonti","year":"2008","unstructured":"Rigamonti E, Chinetti-Gbaguidi G, Staels B. Regulation of Macrophage Functions by PPAR-\u03b1, PPAR-\u03b3, and LXRs in Mice and Men. Arterioscler Thromb Vasc Biol. 2008;28(6):1050\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.107.158998.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.tiv.2019.104700","volume":"62","author":"AC Behr","year":"2020","unstructured":"Behr AC, Plinsch C, Braeuning A, Buhrke T. Activation of human nuclear receptors by perfluoroalkylated substances (PFAS). Toxicol In Vitro. 2020;62:104700. https:\/\/doi.org\/10.1016\/j.tiv.2019.104700.","journal-title":"Toxicol In Vitro"},{"key":"1147_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chemosphere.2013.10.005","volume":"98","author":"SD Geiger","year":"2014","unstructured":"Geiger SD, Xiao J, Ducatman A, Frisbee S, Innes K, Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere. 2014;98:78\u201383. https:\/\/doi.org\/10.1016\/j.chemosphere.2013.10.005.","journal-title":"Chemosphere"},{"issue":"2","key":"1147_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1289\/ehp.0901165","volume":"118","author":"JW Nelson","year":"2010","unstructured":"Nelson JW, Hatch EE, Webster TF. Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population. Environ Health Perspect. 2010;118(2):197\u2013202. https:\/\/doi.org\/10.1289\/ehp.0901165.","journal-title":"Environ Health Perspect"},{"issue":"10","key":"1147_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/aje\/kwp279","volume":"170","author":"K Steenland","year":"2009","unstructured":"Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol. 2009;170(10):1268\u201378. https:\/\/doi.org\/10.1093\/aje\/kwp279.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"1147_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/archpediatrics.2010.163","volume":"164","author":"SJ Frisbee","year":"2010","unstructured":"Frisbee SJ, Shankar A, Knox SS, et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med. 2010;164(9):860\u20139. https:\/\/doi.org\/10.1001\/archpediatrics.2010.163.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"1147_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/EDE.0b013e31829443ee","volume":"24","author":"N Fitz-Simon","year":"2013","unstructured":"Fitz-Simon N, Fletcher T, Luster MI, et al. Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid. Epidemiol Camb Mass. 2013;24(4):569\u201376. https:\/\/doi.org\/10.1097\/EDE.0b013e31829443ee.","journal-title":"Epidemiol Camb Mass"},{"issue":"12","key":"1147_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1289\/ehp.1307943","volume":"122","author":"A Winquist","year":"2014","unstructured":"Winquist A, Steenland K. Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts. Environ Health Perspect. 2014;122(12):1299\u2013305. https:\/\/doi.org\/10.1289\/ehp.1307943.","journal-title":"Environ Health Perspect"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.envres.2012.11.006","volume":"121","author":"M Fisher","year":"2013","unstructured":"Fisher M, Arbuckle TE, Wade M, Haines DA. Do perfluoroalkyl substances affect metabolic function and plasma lipids?\u2013Analysis of the 2007\u20132009, Canadian Health Measures Survey (CHMS) Cycle 1. Environ Res. 2013;121:95\u2013103. https:\/\/doi.org\/10.1016\/j.envres.2012.11.006.","journal-title":"Environ Res"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.envint.2019.01.007","volume":"124","author":"C Donat-Vargas","year":"2019","unstructured":"Donat-Vargas C, Bergdahl IA, Tornevi A, et al. Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors. Environ Int. 2019;124:58\u201365. https:\/\/doi.org\/10.1016\/j.envint.2019.01.007.","journal-title":"Environ Int"},{"issue":"5","key":"1147_CR14","doi-asserted-by":"publisher","first-page":"056001","DOI":"10.1289\/EHP11840","volume":"131","author":"B Liu","year":"2023","unstructured":"Liu B, Zhu L, Wang M, Sun Q. Associations between Per- and Polyfluoroalkyl Substances Exposures and Blood Lipid Levels among Adults\u2014A Meta-Analysis. Environ Health Perspect. 2023;131(5):056001. https:\/\/doi.org\/10.1289\/EHP11840.","journal-title":"Environ Health Perspect"},{"key":"1147_CR15","unstructured":"Feingold KR. Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Blackman MR, et al., eds. Endotext. MDText.com, Inc.; 2000. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305896\/.\u00a0Accessed 6 May 2024."},{"issue":"4","key":"1147_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MOL.0b013e32833b7756","volume":"21","author":"RM Krauss","year":"2010","unstructured":"Krauss RM. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol. 2010;21(4):305\u201311. https:\/\/doi.org\/10.1097\/MOL.0b013e32833b7756.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"1147_CR17","doi-asserted-by":"publisher","first-page":"jah3","DOI":"10.1161\/JAHA.111.000232","volume":"1","author":"MK Jensen","year":"2012","unstructured":"Jensen MK, Rimm EB, Furtado JD, Sacks FM. Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease. J Am Heart Assoc. 2012;1(2):jah3-e000232. https:\/\/doi.org\/10.1161\/JAHA.111.000232.","journal-title":"J Am Heart Assoc"},{"key":"1147_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12940-020-0561-8","volume":"19","author":"G Liu","year":"2020","unstructured":"Liu G, Zhang B, Hu Y, et al. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study. Environ Health. 2020;19:5. https:\/\/doi.org\/10.1186\/s12940-020-0561-8.","journal-title":"Environ Health"},{"issue":"19","key":"1147_CR19","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.111.056986","volume":"124","author":"CO Mendivil","year":"2011","unstructured":"Mendivil CO, Rimm EB, Furtado J, Chiuve SE, Sacks FM. Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. Circulation. 2011;124(19):2065\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.056986.","journal-title":"Circulation"},{"key":"1147_CR20","doi-asserted-by":"publisher","first-page":"706352","DOI":"10.3389\/fendo.2021.706352","volume":"12","author":"A Meneguzzi","year":"2021","unstructured":"Meneguzzi A, Fava C, Castelli M, Minuz P. Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence. Front Endocrinol. 2021;12:706352. https:\/\/doi.org\/10.3389\/fendo.2021.706352.","journal-title":"Front Endocrinol"},{"key":"1147_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.envint.2018.05.051","volume":"119","author":"M Huang","year":"2018","unstructured":"Huang M, Jiao J, Zhuang P, Chen X, Wang J, Zhang Y. Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population. Environ Int. 2018;119:37\u201346. https:\/\/doi.org\/10.1016\/j.envint.2018.05.051.","journal-title":"Environ Int"},{"issue":"6","key":"1147_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jdiacomp.2019.02.004","volume":"33","author":"K Honda-Kohmo","year":"2019","unstructured":"Honda-Kohmo K, Hutcheson R, Ducatman AM, Innes KE, Conway BN. Perfluoroalkyl Substances are Inversely Associated with Coronary Heart Disease in Adults with Diabetes. J Diabetes Complications. 2019;33(6):407\u201312. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.02.004.","journal-title":"J Diabetes Complications"},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.envres.2015.06.033","volume":"142","author":"K Mattsson","year":"2015","unstructured":"Mattsson K, Rignell-Hydbom A, Holmberg S, et al. Levels of perfluoroalkyl substances and risk of coronary heart disease: Findings from a population-based longitudinal study. Environ Res. 2015;142:148\u201354. https:\/\/doi.org\/10.1016\/j.envres.2015.06.033.","journal-title":"Environ Res"},{"issue":"3","key":"1147_CR24","doi-asserted-by":"publisher","first-page":"37007","DOI":"10.1289\/EHP9791","volume":"130","author":"T Schillemans","year":"2022","unstructured":"Schillemans T, Donat-Vargas C, Lindh CH, et al. Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case-Control Study in Sweden. Environ Health Perspect. 2022;130(3):37007. https:\/\/doi.org\/10.1289\/EHP9791.","journal-title":"Environ Health Perspect"},{"key":"1147_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12940-018-0403-0","volume":"17","author":"PM Lind","year":"2018","unstructured":"Lind PM, Salihovic S, Stubleski J, K\u00e4rrman A, Lind L. Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years \u2013 a longitudinal study. Environ Health. 2018;17:59. https:\/\/doi.org\/10.1186\/s12940-018-0403-0.","journal-title":"Environ Health"},{"issue":"1","key":"1147_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12940-024-01074-2","volume":"23","author":"A Biggeri","year":"2024","unstructured":"Biggeri A, Stoppa G, Facciolo L, et al. All-cause, cardiovascular disease and cancer mortality in the population of a large Italian area contaminated by perfluoroalkyl and polyfluoroalkyl substances (1980\u20132018). Environ Health Glob Access Sci Source. 2024;23(1):42. https:\/\/doi.org\/10.1186\/s12940-024-01074-2.","journal-title":"Environ Health Glob Access Sci Source"},{"issue":"10","key":"1147_CR27","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a116211","volume":"135","author":"EB Rimm","year":"1992","unstructured":"Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135(10):1114\u201326. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116211. discussion 1127\u201336.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1147_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/jwh.1997.6.49","volume":"6","author":"GA Colditz","year":"1997","unstructured":"Colditz GA, Manson JE, Hankinson SE. The Nurses\u2019 Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6(1):49\u201362. https:\/\/doi.org\/10.1089\/jwh.1997.6.49.","journal-title":"J Womens Health"},{"key":"1147_CR29","first-page":"1","volume":"56","author":"GA Rose","year":"1968","unstructured":"Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ. 1968;56:1\u2013188.","journal-title":"Monogr Ser World Health Organ"},{"issue":"5","key":"1147_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.amepre.2010.11.022","volume":"40","author":"SE Chiuve","year":"2011","unstructured":"Chiuve SE, Sampson L, Willett WC. The Association Between a Nutritional Quality Index and Risk of Chronic Disease. Am J Prev Med. 2011;40(5):505\u201313. https:\/\/doi.org\/10.1016\/j.amepre.2010.11.022.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1147_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2307\/2335290","volume":"65","author":"RL Prentice","year":"1978","unstructured":"Prentice RL, Breslow NE. Retrospective Studies and Failure Time Models. Biometrika. 1978;65(1):153\u20138. https:\/\/doi.org\/10.2307\/2335290.","journal-title":"Biometrika"},{"key":"1147_CR32","doi-asserted-by":"publisher","first-page":"115600","DOI":"10.1016\/j.envres.2023.115600","volume":"226","author":"D Valvi","year":"2023","unstructured":"Valvi D, Christiani DC, Coull B, et al. Gene-environment interactions in the associations of PFAS exposure with insulin sensitivity and beta-cell function in a Faroese cohort followed from birth to adulthood. Environ Res. 2023;226:115600. https:\/\/doi.org\/10.1016\/j.envres.2023.115600.","journal-title":"Environ Res"},{"issue":"6","key":"1147_CR33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/ajcn\/87.6.1623","volume":"87","author":"JD Furtado","year":"2008","unstructured":"Furtado JD, Campos H, Appel LJ, et al. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Am J Clin Nutr. 2008;87(6):1623\u201330. https:\/\/doi.org\/10.1093\/ajcn\/87.6.1623.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1147_CR34","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ajcn\/36.5.936","volume":"36","author":"JA Baecke","year":"1982","unstructured":"Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936\u201342. https:\/\/doi.org\/10.1093\/ajcn\/36.5.936.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1147_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/aje\/kwaa280","volume":"190","author":"L Al-Shaar","year":"2021","unstructured":"Al-Shaar L, Yuan C, Rosner B, et al. Reproducibility and Validity of a Semiquantitative Food Frequency Questionnaire in Men Assessed by Multiple Methods. Am J Epidemiol. 2021;190(6):1122\u201332. https:\/\/doi.org\/10.1093\/aje\/kwaa280.","journal-title":"Am J Epidemiol"},{"key":"1147_CR36","unstructured":"Li R, Hertzmark E, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV9 Macro. https:\/\/ysph.yale.edu\/cmips\/research\/software\/lgtphcurv9_7-3-2011_340182_284_47911_v2.pdf."},{"issue":"6","key":"1147_CR37","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/oby.23755","volume":"31","author":"P Grandjean","year":"2023","unstructured":"Grandjean P, Meddis A, Nielsen F, et al. Weight loss relapse associated with exposure to perfluorinated alkylate substances. Obes Silver Spring Md. 2023;31(6):1686\u201396. https:\/\/doi.org\/10.1002\/oby.23755.","journal-title":"Obes Silver Spring Md"},{"key":"1147_CR38","unstructured":"Hertzmark E, Pazaris M, Spiegelman D. The SAS MEDIATE Macro. https:\/\/ysph.yale.edu\/cmips\/research\/software\/mediate_340185_284_47911_v2.pdf."},{"issue":"18","key":"1147_CR39","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/archinternmed.2012.3393","volume":"172","author":"A Shankar","year":"2012","unstructured":"Shankar A, Xiao J, Ducatman A. Perfluorooctanoic acid and cardiovascular disease in US adults. Arch Intern Med. 2012;172(18):1397\u2013403. https:\/\/doi.org\/10.1001\/archinternmed.2012.3393.","journal-title":"Arch Intern Med"},{"issue":"2","key":"1147_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2190\/NS.18.2.d","volume":"18","author":"P Anderson-Mahoney","year":"2008","unstructured":"Anderson-Mahoney P, Kotlerman J, Takhar H, Gray D, Dahlgren J. Self-reported health effects among community residents exposed to perfluorooctanoate. New Solut J Environ Occup Health Policy NS. 2008;18(2):129\u201343. https:\/\/doi.org\/10.2190\/NS.18.2.d.","journal-title":"New Solut J Environ Occup Health Policy NS"},{"issue":"1","key":"1147_CR41","doi-asserted-by":"publisher","first-page":"147916411989222","DOI":"10.1177\/1479164119892223","volume":"17","author":"R Hutcheson","year":"2020","unstructured":"Hutcheson R, Innes K, Conway B. Perfluoroalkyl substances and likelihood of stroke in persons with and without diabetes. Diab Vasc Dis Res. 2020;17(1):1479164119892223. https:\/\/doi.org\/10.1177\/1479164119892223.","journal-title":"Diab Vasc Dis Res"},{"key":"1147_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.envint.2016.03.012","volume":"91","author":"KY Christensen","year":"2016","unstructured":"Christensen KY, Raymond M, Thompson BA, Anderson HA. Perfluoroalkyl substances in older male anglers in Wisconsin. Environ Int. 2016;91:312\u20138. https:\/\/doi.org\/10.1016\/j.envint.2016.03.012.","journal-title":"Environ Int"},{"issue":"6","key":"1147_CR43","doi-asserted-by":"publisher","first-page":"67007","DOI":"10.1289\/EHP10393","volume":"130","author":"X Wen","year":"2022","unstructured":"Wen X, Wang M, Xu X, Li T. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study. Environ Health Perspect. 2022;130(6):67007. https:\/\/doi.org\/10.1289\/EHP10393.","journal-title":"Environ Health Perspect"},{"key":"1147_CR44","unstructured":"C8 Science Panel. Probable Link Evaluation for heart disease (including high blood pressure, high cholesterol, coronary artery disease). 2012. http:\/\/www.c8sciencepanel.org\/pdfs\/Probable_Link_C8_Heart_Disease_29Oct2012.pdf.\u00a0Accessed 17 Oct 2024."},{"issue":"1","key":"1147_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12940-020-00656-0","volume":"19","author":"G Pitter","year":"2020","unstructured":"Pitter G, Zare Jeddi M, Barbieri G, et al. Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults. Environ Health Glob Access Sci Source. 2020;19(1):102. https:\/\/doi.org\/10.1186\/s12940-020-00656-0.","journal-title":"Environ Health Glob Access Sci Source"},{"key":"1147_CR46","doi-asserted-by":"publisher","first-page":"106446","DOI":"10.1016\/j.envint.2021.106446","volume":"151","author":"C Osorio-Y\u00e1\u00f1ez","year":"2021","unstructured":"Osorio-Y\u00e1\u00f1ez C, Sanchez-Guerra M, Cardenas A, et al. Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study. Environ Int. 2021;151:106446. https:\/\/doi.org\/10.1016\/j.envint.2021.106446.","journal-title":"Environ Int"},{"key":"1147_CR47","doi-asserted-by":"publisher","unstructured":"Ding N, Karvonen-Gutierrez CA, Mukherjee B, Calafat AM, Harlow SD, Park SK. Per- and Polyfluoroalkyl Substances and Incident Hypertension in Multi-Racial\/Ethnic Women: The Study of Women\u2019s Health Across the Nation. Hypertens Dallas Tex 1979. 2022;79(8):1876\u20131886. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18809.","DOI":"10.1161\/HYPERTENSIONAHA.121.18809"},{"key":"1147_CR48","doi-asserted-by":"publisher","first-page":"1173101","DOI":"10.3389\/fpubh.2023.1173101","volume":"11","author":"F Xiao","year":"2023","unstructured":"Xiao F, An Z, Lv J, et al. Association between per- and polyfluoroalkyl substances and risk of hypertension: a systematic review and meta-analysis. Front Public Health. 2023;11:1173101. https:\/\/doi.org\/10.3389\/fpubh.2023.1173101.","journal-title":"Front Public Health"},{"issue":"6","key":"1147_CR49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1536\/ihj.23-036","volume":"64","author":"J Yang","year":"2023","unstructured":"Yang J, Zhang K, Shen C, et al. The Association of Hypertension with Perfluoroalkyl and Polyfluoroalkyl Substances. Int Heart J. 2023;64(6):1079\u201387. https:\/\/doi.org\/10.1536\/ihj.23-036.","journal-title":"Int Heart J"},{"issue":"Pt A","key":"1147_CR50","doi-asserted-by":"publisher","first-page":"113225","DOI":"10.1016\/j.envres.2022.113225","volume":"212","author":"E Batzella","year":"2022","unstructured":"Batzella E, Girardi P, Russo F, et al. Perfluoroalkyl substance mixtures and cardio-metabolic outcomes in highly exposed male workers in the Veneto Region: A mixture-based approach. Environ Res. 2022;212(Pt A):113225. https:\/\/doi.org\/10.1016\/j.envres.2022.113225.","journal-title":"Environ Res"},{"issue":"Pt A","key":"1147_CR51","doi-asserted-by":"publisher","first-page":"108743","DOI":"10.1016\/j.envres.2019.108743","volume":"179","author":"P Girardi","year":"2019","unstructured":"Girardi P, Merler E. A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid. Environ Res. 2019;179(Pt A):108743. https:\/\/doi.org\/10.1016\/j.envres.2019.108743.","journal-title":"Environ Res"},{"key":"1147_CR52","unstructured":"Biomonitoring Data Tables for Environmental Chemicals | CDC. April 30, 2024. https:\/\/www.cdc.gov\/exposurereport\/data_tables.html.\u00a0Accessed 6 May 2024."},{"key":"1147_CR53","doi-asserted-by":"publisher","unstructured":"Fan Y, Li X, Xu Q, et al. Serum albumin mediates the effect of multiple per- and polyfluoroalkyl substances on serum lipid levels. Environ Pollut Barking Essex 1987. 2020;266(Pt 2). https:\/\/doi.org\/10.1016\/j.envpol.2020.115138.","DOI":"10.1016\/j.envpol.2020.115138"},{"key":"1147_CR54","doi-asserted-by":"publisher","first-page":"106117","DOI":"10.1016\/j.envint.2020.106117","volume":"145","author":"C Canova","year":"2020","unstructured":"Canova C, Barbieri G, Zare Jeddi M, et al. Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region. Environ Int. 2020;145:106117. https:\/\/doi.org\/10.1016\/j.envint.2020.106117.","journal-title":"Environ Int"},{"key":"1147_CR55","doi-asserted-by":"publisher","unstructured":"Morton AM, Koch M, Mendivil CO, et al. Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk. JCI Insight. 2018;3(4):e98045, 98045. https:\/\/doi.org\/10.1172\/jci.insight.98045.","DOI":"10.1172\/jci.insight.98045"},{"issue":"2","key":"1147_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/MED.0000000000000136","volume":"22","author":"AB Kohan","year":"2015","unstructured":"Kohan AB. Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease. Curr Opin Endocrinol Diabetes Obes. 2015;22(2):119\u201325. https:\/\/doi.org\/10.1097\/MED.0000000000000136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"1147_CR57","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1289\/ehp.0901827","volume":"118","author":"K Steenland","year":"2010","unstructured":"Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect. 2010;118(8):1100\u20138. https:\/\/doi.org\/10.1289\/ehp.0901827.","journal-title":"Environ Health Perspect"},{"issue":"24","key":"1147_CR58","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1021\/es201964x","volume":"45","author":"CY Lin","year":"2011","unstructured":"Lin CY, Wen LL, Lin LY, et al. Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan. Environ Sci Technol. 2011;45(24):10691\u20138. https:\/\/doi.org\/10.1021\/es201964x.","journal-title":"Environ Sci Technol"},{"issue":"11","key":"1147_CR59","doi-asserted-by":"publisher","first-page":"13819","DOI":"10.1007\/s11356-020-11593-3","volume":"28","author":"RB Jain","year":"2021","unstructured":"Jain RB, Ducatman A. Associations between apolipoprotein B and selected perfluoroalkyl substances among diabetics and nondiabetics. Environ Sci Pollut Res Int. 2021;28(11):13819\u201328. https:\/\/doi.org\/10.1007\/s11356-020-11593-3.","journal-title":"Environ Sci Pollut Res Int"},{"issue":"2","key":"1147_CR60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.toxlet.2012.05.007","volume":"212","author":"E Scharmach","year":"2012","unstructured":"Scharmach E, Buhrke T, Lichtenstein D, Lampen A. Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4\u03b1). Toxicol Lett. 2012;212(2):106\u201312. https:\/\/doi.org\/10.1016\/j.toxlet.2012.05.007.","journal-title":"Toxicol Lett"},{"key":"1147_CR61","doi-asserted-by":"publisher","first-page":"794739","DOI":"10.1155\/2010\/794739","volume":"2010","author":"MB Rosen","year":"2010","unstructured":"Rosen MB, Schmid JR, Corton JC, et al. Gene Expression Profiling in Wild-Type and PPAR\u03b1-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPAR\u03b1-Independent Effects. PPAR Res. 2010;2010:794739. https:\/\/doi.org\/10.1155\/2010\/794739.","journal-title":"PPAR Res"},{"issue":"2","key":"1147_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.etap.2007.04.003","volume":"24","author":"KH Harada","year":"2007","unstructured":"Harada KH, Hashida S, Kaneko T, et al. Biliary excretion and cerebrospinal fluid partition of perfluorooctanoate and perfluorooctane sulfonate in humans. Environ Toxicol Pharmacol. 2007;24(2):134\u20139. https:\/\/doi.org\/10.1016\/j.etap.2007.04.003.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"10","key":"1147_CR63","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00216-019-02263-6","volume":"412","author":"S Salihovi\u0107","year":"2020","unstructured":"Salihovi\u0107 S, Dickens AM, Schoultz I, et al. Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2020;412(10):2251\u20139. https:\/\/doi.org\/10.1007\/s00216-019-02263-6.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"1147_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ijms21020399","volume":"21","author":"L De Toni","year":"2020","unstructured":"De Toni L, Radu CM, Sabovic I, et al. Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro\u2013Octanoic Acid: Role of Impaired Platelet Aggregation. Int J Mol Sci. 2020;21(2):399. https:\/\/doi.org\/10.3390\/ijms21020399.","journal-title":"Int J Mol Sci"}],"container-title":["Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12940-024-01147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12940-024-01147-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12940-024-01147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:05:17Z","timestamp":1733223917000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehjournal.biomedcentral.com\/articles\/10.1186\/s12940-024-01147-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1186\/s12940-024-01147-2","relation":{},"ISSN":["1476-069X"],"issn-type":[{"value":"1476-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Grandjean has provided paid expert assistance in legal cases involving PFAS-exposed populations. All other authors declare no competing interests associated with the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}